BRIEF—Corteria raises $71 million in series A round

Cardiology specialist Corteria Pharmaceuticals has raised $71 million in a series A financing co-led by American investor OrbiMed and EU-based Jeito Capital.

Corteria, a French company focused on unaddressed heart failure subpopulations, was founded in 2021 by two Sanofi veterans, including the former head of cardiovascular research.

The money will be used to take a pipeline of cardiovascular candidates into the clinic, including two programs in-licensed from Sanofi.

Kurma Partners managing partner Thierry Laugel, one of the firm’s early backers, said Corteria was “at a turning point of entering the clinic with its lead asset early next year and validating its unique positioning in well-defined heart failure subpopulations with high unmet medical needs.”